BACKGROUND: Anti-TNFα is increasingly used as treatment for immune mediated inflammatory diseases (IMID), such as inflammatory bowel disease (IBD), rheumatoid arthritis (RA) and psoriasis (PS). However, the impact of anti-TNFα during pregnancy on mother and newborn is under debate. This requires a sound knowledge of the effects of this treatment on pregnancy and neonatal outcomes. OBJECTIVES: To assess pregnancy and neonatal outcomes after anti-TNFα therapy during pregnancy in women with IMID, specifically IBD, RA and PS. METHODS: We performed a systematic review and meta-analysis of 39 studies assessing pregnancy and neonatal outcomes of women with IMID exposed to anti-TNFα agents during pregnancy. We used a random-effects model to determi...
Background/Aims The onset of inflammatory bowel disease (IBD) usually occurs at young age, and there...
International audienceIntroduction: Over the last decade, antitumor necrosis factor (anti TNF) thera...
Objective Antitumour necrosis factor (TNF) during pregnancy in patients with IBD is related to high ...
Item does not contain fulltextBACKGROUND: Anti-TNFα is increasingly used as treatment for immune med...
Background and Aims: Inflammatory bowel disease (IBD) commonly affects women during their reproducti...
International audienceOBJECTIVES:Inflammatory bowel diseases (IBD) need long-term treatment, which c...
International audienceBACKGROUND: The safety of anti-tumour necrosis factor (TNF) agents during preg...
Objective As many inflammatory rheumatic diseases affect patients in childbearing age, some concern ...
Background The safety of anti-tumour necrosis factor (TNF) agents during pregnancy is a major concer...
This systematic review examined on whether there are more adverse pregnancy outcomes among inflammat...
AIMS: TNF-α inhibitors are considered relatively safe in pregnancy but experience is still limited. ...
OBJECTIVES: The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during ...
OBJECTIVES: The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during ...
Inflammatory bowel disease (IBD) affects young people of reproductive age. Therefore, a broad discus...
Background/Aims The onset of inflammatory bowel disease (IBD) usually occurs at young age, and there...
International audienceIntroduction: Over the last decade, antitumor necrosis factor (anti TNF) thera...
Objective Antitumour necrosis factor (TNF) during pregnancy in patients with IBD is related to high ...
Item does not contain fulltextBACKGROUND: Anti-TNFα is increasingly used as treatment for immune med...
Background and Aims: Inflammatory bowel disease (IBD) commonly affects women during their reproducti...
International audienceOBJECTIVES:Inflammatory bowel diseases (IBD) need long-term treatment, which c...
International audienceBACKGROUND: The safety of anti-tumour necrosis factor (TNF) agents during preg...
Objective As many inflammatory rheumatic diseases affect patients in childbearing age, some concern ...
Background The safety of anti-tumour necrosis factor (TNF) agents during pregnancy is a major concer...
This systematic review examined on whether there are more adverse pregnancy outcomes among inflammat...
AIMS: TNF-α inhibitors are considered relatively safe in pregnancy but experience is still limited. ...
OBJECTIVES: The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during ...
OBJECTIVES: The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during ...
Inflammatory bowel disease (IBD) affects young people of reproductive age. Therefore, a broad discus...
Background/Aims The onset of inflammatory bowel disease (IBD) usually occurs at young age, and there...
International audienceIntroduction: Over the last decade, antitumor necrosis factor (anti TNF) thera...
Objective Antitumour necrosis factor (TNF) during pregnancy in patients with IBD is related to high ...